Petra Schlick

Title: Petra Schlick: Innovator in Vaccine Development

Introduction

Petra Schlick is a notable inventor based in Vienna, Austria, whose contributions to the field of vaccine development have garnered attention in the scientific community. As an inventor, she has a strong focus on creating innovative solutions to combat viral diseases.

Latest Patents

Petra Schlick holds a patent titled "Flaviviridae mutants comprising a deletion in the capsid protein for use as vaccines". This groundbreaking invention involves a mutant virus from the Flaviviridae family that includes a deletion in the capsid protein of at least 20 successive amino acids. Importantly, this mutant virus does not contain further deletions, substitutions, or insertion mutations apart from the potential substitutions of adjacent amino acids. This advancement has significant implications for the development of effective vaccines.

Career Highlights

Currently, Petra Schlick is employed at Valneva Austria GmbH, a company that emphasizes innovative solutions for infectious disease treatments and prevention. Her role has positioned her at the forefront of vaccine research and development, allowing her to make substantial contributions to healthcare.

Collaborations

Throughout her career, Petra has collaborated with esteemed colleagues, including Franz Xaver Heinz and Christian Mandl. These collaborations have leveraged diverse expertise in the field, enhancing the innovative potential of their research and leading to advancements in vaccine technology.

Conclusion

Petra Schlick exemplifies the spirit of innovation in the realm of vaccine development. With her patent on Flaviviridae mutants, she has taken significant steps towards addressing global health challenges. Her work at Valneva Austria GmbH, combined with her collaborations, underscores the importance of teamwork and innovation in advancing medical science.